VOYA Investment Management’s Tenaya Therapeutics TNYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-18,259
Closed -$26.1K 2729
2024
Q4
$26.1K Sell
18,259
-1,275
-7% -$2.86K ﹤0.01% 2726
2024
Q3
$37.7K Hold
19,534
﹤0.01% 2789
2024
Q2
$60.6K Buy
19,534
+4,767
+32% +$19.7K ﹤0.01% 2773
2024
Q1
$77.2K Sell
14,767
-3,618
-20% -$17.3K ﹤0.01% 2669
2023
Q4
$59.6K Hold
18,385
﹤0.01% 2833
2023
Q3
$46.9K Hold
18,385
﹤0.01% 2861
2023
Q2
$108K Buy
18,385
+648
+4% +$3.77K ﹤0.01% 2768
2023
Q1
$50.5K Buy
17,737
+7,154
+68% +$20.1K ﹤0.01% 2801
2022
Q4
$21.3K Hold
10,583
﹤0.01% 2911
2022
Q3
$30.7K Hold
10,583
﹤0.01% 2930
2022
Q2
$60K Buy
+10,583
New +$85.6K ﹤0.01% 2716

Other funds holding TNYA

VOYA Investment Management's TNYA Position: Q1 2025 in Review

VOYA Investment Management sold out of Tenaya Therapeutics (TNYA) in Q1 2025, closing a stake of 18,259 shares — an estimated $26.1K sold.

VOYA Investment Management first reported a position in TNYA in Q2 2022 and held it in 11 quarters. The position peaked at $108K in Q2 2023. 107 funds tracked by Wall St. Rank hold TNYA as of Q1 2025.

  • VOYA Investment Management reported no remaining Tenaya Therapeutics position as of Q1 2025 after selling out during the quarter.
  • VOYA Investment Management sold 18,259 Tenaya Therapeutics shares in Q1 2025, an estimated $26.1K.
  • VOYA Investment Management first reported a position in Tenaya Therapeutics in Q2 2022 and held it in 11 quarters.
  • VOYA Investment Management's Tenaya Therapeutics position peaked at $108K in Q2 2023.
  • 107 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2025.

Based on VOYA Investment Management's 13F filing for Q1 2025, filed 15 May 2025.